NCT00352287View on ClinicalTrials.gov

Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

April 30, 2005

Conditions
ObesityMetabolic SyndromeImpaired Glucose Tolerance
Interventions
DRUG

Recombinant human growth hormone; pioglitazone

Trial Locations (1)

94304

Veterans Affairs Palo Alto Health Care System, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT00352287 - Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults | Biotech Hunter | Biotech Hunter